A detailed history of Wade G W & Inc transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Wade G W & Inc holds 17,544 shares of EW stock, worth $1.15 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
17,544
Previous 17,554 0.06%
Holding current value
$1.15 Million
Previous $1.22 Million 10.03%
% of portfolio
0.04%
Previous 0.05%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 08, 2024

SELL
$61.71 - $77.76 $617 - $777
-10 Reduced 0.06%
17,544 $1.34 Million
Q3 2023

Nov 08, 2023

SELL
$69.28 - $93.38 $123,734 - $166,776
-1,786 Reduced 9.23%
17,554 $1.22 Million
Q2 2023

Aug 10, 2023

SELL
$81.41 - $94.33 $6,512 - $7,546
-80 Reduced 0.41%
19,340 $1.82 Million
Q1 2023

May 09, 2023

SELL
$74.26 - $84.51 $25,991 - $29,578
-350 Reduced 1.77%
19,420 $1.61 Million
Q4 2022

Feb 10, 2023

BUY
$68.3 - $87.44 $308,442 - $394,879
4,516 Added 29.61%
19,770 $1.48 Million
Q3 2022

Nov 10, 2022

BUY
$82.37 - $107.29 $53,540 - $69,738
650 Added 4.45%
15,254 $1.26 Million
Q2 2022

Aug 09, 2022

BUY
$86.5 - $128.27 $30,275 - $44,894
350 Added 2.46%
14,604 $1.39 Million
Q1 2022

May 10, 2022

BUY
$101.96 - $128.34 $12,948 - $16,299
127 Added 0.9%
14,254 $1.68 Million
Q4 2021

Feb 09, 2022

BUY
$106.37 - $130.68 $38,931 - $47,828
366 Added 2.66%
14,127 $1.83 Million
Q3 2021

Nov 03, 2021

BUY
$102.91 - $122.75 $10,085 - $12,029
98 Added 0.72%
13,761 $1.56 Million
Q2 2021

Aug 12, 2021

SELL
$83.84 - $104.76 $2,515 - $3,142
-30 Reduced 0.22%
13,663 $1.42 Million
Q1 2021

May 05, 2021

BUY
$78.68 - $90.67 $648,559 - $747,392
8,243 Added 151.25%
13,693 $1.15 Million
Q4 2020

Feb 03, 2021

BUY
$71.69 - $91.23 $390,710 - $497,203
5,450 New
5,450 $497,000

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $40.5B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Wade G W & Inc Portfolio

Follow Wade G W & Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wade G W & Inc, based on Form 13F filings with the SEC.

News

Stay updated on Wade G W & Inc with notifications on news.